New Aesica Manufacturing Facility
DHA secure permission for new manufacturing facility in Queensborough, Kent
DHA secured detailed planning permission for the construction of a new high capacity manufacturing facility for the manufacture of a treatment for Type 2 diabetes together with a warehouse facility and associated buildings on behalf of Aesica Queenborough Limited at their existing facility at Queenborough, Kent.
The new facility will allow Aesica to help meet a growing world demand for the for Type 2 Diabetes products. The production facility and associated buildings comprise 6,933 sq m and the warehouse facility a further 2,734 sq m.
As part of the application process DHA also provided the draft Section 106 Unilateral Undertaking required by the Local Planning Authority to help secure local job opportunities through the construction phase and the operation of the new facility.
DHA have subsequently been instructed to work with the other consultants to discharge the planning conditions.
The facility is currently under construction with the first Phase being completed at the end of 2013.